CAT# | CPM-1-0715 |
Sequence | RRRWRRLTV |
Size | 100 test | Storage | 4 ̊C | Epitope Origin | EBV LMP2 RRR | MHC Restriction | HLA-B_27_05 | Conjugate | PE |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0568 | HLA-A_02_01 HBV core tetramer-FLPSDFFPSV-PE labeled | Inquiry | ||
CPM-1-0385 | HLA-A_02_01 Mtb Rv1614 tetramer-FLYELIWNV-APC labeled | Inquiry | ||
CPM-1-0283 | HLA-A_24_02 HTLV-1 Tax301-309 tetramer-SFHSLHLLF-APC labeled | Inquiry | ||
CPM-1-0541 | HLA-A_02_01 PR-1 tetramer-VLQELNVTV-PE labeled | Inquiry | ||
CPM-1-0296 | HLA-A_24_02 GPC3 tetramer-EYILSLEEL-APC labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Long-term potentiation (LTP) is a persistent synaptic enhancement which is thought to be a substrate for memory. ...
NF-кB activator 1, named Act1, is a 60-kDa (574-aa) polypeptide. Based on its interaction with IKKγ, Act1can be ...
PM102 is a novel synthetic peptide that effectively reverses the anticoagulant effect of heparin. It can be used ...
Palmitoyl Tripeptide-1 is also called Part of Matrixyl 3000. Palmitoyl Oligopeptide and Pal-GHK are believed to be able to st ...
10Panx is a panx 1 mimetic inhibitor that easily and reversibly inhibits panx1 currents. In cells that are diffi ...